Capricor Therapeutics, Inc. (CAPR) NASDAQ

5.79

+0.185(+3.30%)

Updated at November 17 02:35PM

Currency In USD

Valuation

Market Cap486.02M
Enterprise Value476.19M
P/E Ratio-3.78
PEG Ratio0.24
Price/Sales Ratio19.75
Price/Book Ratio2.52
Enterprise/Revenue18.09
Enterprise/EBITDA-3.44

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-5.22
Operating Margin-5.48

Management Effectiveness

Return On Assets-0.52
Return On Equity-0.63

Income Statement

Revenue22.27M
Revenue/Share0.29
Gross Profit-27.7M
EBITDA-41.14M
Net Income-40.47M
Diluted EPS-1.15

Balance Sheet

Total Cash98.57M
Total Cash/Share2.69
Total Debt14.54M
Total Debt/Equity0.01
Current Ratio4.37
Book Value Per Share2.3

Price History

52-Week Change-68.53
52-Week High20.75
52-Week Low5.43
Moving Average 50 Days6.52
Moving Average 200 Days9.53

Statistics

Average Volume1.37M
Shares Outstanding45.72M
% Held by Institutions31.65

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJune 05, 2019